💉 Actide 50 mcg Injection | Octreotide Acetate | Hormonal Disorder & Oncology Support | Export Supplier
Actide 50 mcg Injection contains Octreotide Acetate, a synthetic somatostatin analogue used in the management of acromegaly, neuroendocrine tumors, and severe diarrhea/flushing associated with carcinoid syndrome. It works by inhibiting excess hormone secretion.
🔹 Product Category
Specialty Medicine (Hormonal Therapy / Somatostatin Analogue)
🔹 Composition
Octreotide Acetate 50 mcg
🔹 Indications
✔ Acromegaly
✔ Neuroendocrine Tumors
✔ Carcinoid Syndrome (Diarrhea & Flushing)
✔ Hormone-Secreting Tumors
🔹 Key Benefits
✔ Controls excess hormone secretion
✔ Reduces tumor-related symptoms
✔ Improves quality of life
✔ Widely used in endocrinology & oncology
🔹 Dosage & Administration
✔ Administered via subcutaneous or IV injection
✔ Given under strict medical supervision
✔ Dosage based on patient condition
🔹 Packaging
✔ Ampoule / Vial Packaging
✔ Cold Chain Export Packaging Available
✔ Bulk Supply Supported
✔ Private Labeling Available
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets & Cities
🇺🇸 USA: New York, Chicago, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore
🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi
🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi
🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ Endocrinology Medicines
✔ Specialty Pharmaceutical Products
📞 Instant Support – Call / WhatsApp Now
📲 +91 8007161282
📲 +91 9970011496
🌐 Websites
🔹 www.pacificmedicines.com
🔹 www.indocares.com
🔹 www.indiamedexport.com
📧 Email
✉️ sales@pacificmedicines.com